ArticleJournal of oral microbiology2026
Metformin-loaded mesoporous calcium silicate nanoparticles against alkaline-resistant
Article in Journal of oral microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: Metformin-loaded MCSNs (MCSNs-Met) were characterized for physicochemical properties, Met release, alkalinity, cytocompatibility, and dentinal tubule penetration. Antibiofilm activity against highly alkaline-resistant Results: MCSNs-Met exhibited a uniform mesoporous structure, sustained Met release and alkalinity, favorable cytocompatibility, and enhanced dentinal tubule penetration. Compared with MCSNs alone, MCSNs-Met more effectively disrupted Conclusions: MCSNs-Met integrates sustained Met delivery with the intrinsic alkaline and bioactive properties of calcium silicate nanoparticles, thereby enhancing control of highly alkaline-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.